These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

425 related articles for article (PubMed ID: 3289152)

  • 21. In vivo administration of Fab' fragments of anti-L3T4 (GK1.5) antibody inhibits the T helper cell function of murine lymph node cells.
    Street NE; Uyemura K; Sanders VM; Uhr JW; Vitetta ES
    Cell Immunol; 1989 Apr; 120(1):75-81. PubMed ID: 2522831
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term humoral unresponsiveness in vivo, induced by treatment with monoclonal antibody against L3T4.
    Goronzy J; Weyand CM; Fathman CG
    J Exp Med; 1986 Sep; 164(3):911-25. PubMed ID: 3091757
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Induction of hyperacute rejection of skin allografts by CD8+ lymphocytes.
    Yoshimura R; Chargui J; Aitouche A; Veyron P; Touraine JL
    Transplantation; 2000 Apr; 69(7):1452-7. PubMed ID: 10798770
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immune regulation by monoclonal antibodies: failure to enhance mouse skin allografts.
    Lems SP; Tax WJ; Capel PJ; Koene RA
    J Immunol; 1983 Jul; 131(1):86-91. PubMed ID: 6345667
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Failure to induce chimerism or tolerance in mice with monoclonal anti-T cell antibodies plus allogeneic bone marrow infusion.
    Auchincloss H; Ghobrial RR; Shea S; Pierson RN; Winn HJ
    Transplant Proc; 1988 Dec; 20(6):1190-3. PubMed ID: 3059601
    [No Abstract]   [Full Text] [Related]  

  • 26. Roles of CD4+ and CD8+ cells in islet allo- and xeno-graft rejection.
    Gotoh M; Monden M; Yamamoto H; Kawai M; Ichikawa T; Mori T; Uenaka A; Nakayama E
    Horm Metab Res Suppl; 1990; 25():173-6. PubMed ID: 1982441
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A synthetic CD4-CDR3 peptide analog enhances skin allograft survival across a MHC class II barrier.
    Koch U; Choksi S; Marcucci L; Korngold R
    J Immunol; 1998 Jul; 161(1):421-9. PubMed ID: 9647252
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Induction of immune tolerance by administration of monoclonal antibody to L3T4.
    Gutstein NL; Seaman WE; Scott JH; Wofsy D
    J Immunol; 1986 Aug; 137(4):1127-32. PubMed ID: 3090139
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Administration of F(ab')2 fragments of monoclonal antibody to L3T4 inhibits humoral immunity in mice without depleting L3T4+ cells.
    Gutstein NL; Wofsy D
    J Immunol; 1986 Dec; 137(11):3414-9. PubMed ID: 3097122
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of anti-L3T4 and anti-LYT2 monoclonal antibody therapy on cardiac allograft survival in presensitized recipients.
    Madsen JC; Wood KJ; Morris PJ
    Transplant Proc; 1989 Feb; 21(1 Pt 1):1022. PubMed ID: 2495588
    [No Abstract]   [Full Text] [Related]  

  • 31. Importance of natural killer cells in the rejection of hamster skin xenografts.
    Gourlay WA; Chambers WH; Monaco AP; Maki T
    Transplantation; 1998 Mar; 65(5):727-34. PubMed ID: 9521210
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prolonged or permanent survival of skin allografts induced by monoclonal antibodies against lymphocyte subpopulations.
    Holán V; Hasek M
    Folia Biol (Praha); 1985; 31(1):50-8. PubMed ID: 2857666
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Induction of anti-allo-class I H-2 tolerance by inactivation of CD8+ helper T cells, and reversal of tolerance through introduction of third-party helper T cells.
    Kitagawa S; Sato S; Hori S; Hamaoka T; Fujiwara H
    J Exp Med; 1990 Jul; 172(1):105-13. PubMed ID: 2141624
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vivo use of monoclonal antibodies against murine T cell antigens.
    Ghobrial RR; Boublik M; Winn HJ; Auchincloss H
    Clin Immunol Immunopathol; 1989 Sep; 52(3):486-506. PubMed ID: 2788053
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Study on the improved effect of anti-TCR alpha beta monoclonal antibody on the induction of transplantation tolerance to the allogeneic skin graft in mice and its mechanisms].
    Hao J; Liu J; Xie S
    Zhonghua Yi Xue Za Zhi; 2001 May; 81(10):593-6. PubMed ID: 11798930
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunologically mediated regression of a murine lymphoma after treatment with anti-L3T4 antibody. A consequence of removing L3T4+ suppressor T cells from a host generating predominantly Lyt-2+ T cell-mediated immunity.
    Awwad M; North RJ
    J Exp Med; 1988 Dec; 168(6):2193-206. PubMed ID: 2974065
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-TCR mAb induces peripheral tolerance to alloantigens and delays islet allograft rejection in autoimmune diabetic NOD mice.
    Deng R; Khattar M; Xie A; Schroder PM; He X; Chen W; Stepkowski SM
    Transplantation; 2014 Jun; 97(12):1216-24. PubMed ID: 24854475
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CD4+ T Cell Help Is Mandatory for Naive and Memory Donor-Specific Antibody Responses: Impact of Therapeutic Immunosuppression.
    Chen CC; Koenig A; Saison C; Dahdal S; Rigault G; Barba T; Taillardet M; Chartoire D; Ovize M; Morelon E; Defrance T; Thaunat O
    Front Immunol; 2018; 9():275. PubMed ID: 29515582
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term survival of skin allografts induced by donor splenocytes and anti-CD154 antibody in thymectomized mice requires CD4(+) T cells, interferon-gamma, and CTLA4.
    Markees TG; Phillips NE; Gordon EJ; Noelle RJ; Shultz LD; Mordes JP; Greiner DL; Rossini AA
    J Clin Invest; 1998 Jun; 101(11):2446-55. PubMed ID: 9616216
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-L3T4 monoclonal antibodies prolong survival of Ia-antigen disparate skin allografts.
    Holán V
    Folia Biol (Praha); 1988; 34(2):65-71. PubMed ID: 3294049
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.